How do I buy Kezar Life Sciences (KZR) stock?

You can purchase shares of Kezar Life Sciences (NASDAQ:KZR) through any online brokerage.View our list of the best stock brokerages

Who are Kezar Life Sciences (KZR) competitors?

Other companies in Kezar Life Sciences’s space includes: Aligos Therapeutics Inc (NASDAQ:ALGS), OS Therapies Inc (AMEX:OSTX), MAIA Biotechnology Inc (AMEX:MAIA), ABVC BioPharma Inc (NASDAQ:ABVC) and Fortress Biotech Inc (NASDAQ:FBIOP).

What is the forecast, or price target, for Kezar Life Sciences (KZR) stock?

Kezar Life Sciences has a consensus price target of $6.00.

What is the current price for Kezar Life Sciences (KZR)?

The stock price for Kezar Life Sciences (NASDAQ: KZR) is $6.48 last updated January 13, 2026 at 7:56 AM EST.

Does Kezar Life Sciences (KZR) pay a dividend?

There are no upcoming dividends for Kezar Life Sciences.

When is Kezar Life Sciences (NASDAQ:KZR) reporting earnings?

Kezar Life Sciences does not have any upcoming earnings scheduled.

Is Kezar Life Sciences (KZR) going to split?

There is no upcoming split for Kezar Life Sciences.

What sector and industry does Kezar Life Sciences (KZR) operate in?

Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Kezar Life Sciences (KZR) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

Comments